Braun to Novo Nordisk CEO: “Why are Americans paying more for the same drug?”
On Tuesday, U.S. Senator Mike Braun (R-Ind.) questioned Novo Nordisk CEO Lars Fruergaard Jørgensen at the Senate Health, Education, Labor, and Pensions Committee hearing about the high prices of the…
Read More